Clinical trial
Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre, Phase III Trial to Investigate the Efficacy, Safety and Tolerability of Naloxone HCl PR Tablets in Patients With Opioid Induced Constipation
NCT03687268 is registered in ClinicalTrials.gov with Develco Pharma Schweiz AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre, Phase III Trial to Investigate the Efficacy, Safety and Tolerability of Naloxone HCl PR Tablets in Patients With Opioid Induced Constipation
- Lead sponsor
- Develco Pharma Schweiz AG
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- July 31, 2017
- Completion date
- December 31, 2019
- Enrollment
- 1,500 (estimated)
- Sites
- 104
Conditions
As the registry lists them; a condition with its own page is linked.